Company / PP&E per Share
Rapport Therapeutics, Inc. PP&E per Share History
FY2023-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.17
FY2024
5-year range
$0.17 / $1.27
FY2023-FY2024
Trend
-86.6%
vs FY2023
Sector context
#87 of 191
Health Care
What the data says
At $0.17, Rapport Therapeutics, Inc.'s pp&e per share ranks #87 of 191 in the Health Care sector.
Based on SEC 10-K filings.
0.17 in FY2024.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#87 of 191 in Health CareTop 46% of 191This company $0.17 Sector average $22.34
▼
-99.2% below sector average
Key checks
Key Insights
- In FY2024, pp&e per share decreased 86.6% year-over-year.
- Ranks #87 out of 191 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 13.36 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.17 | -86.6% |
| FY2023 | $1.27 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026